The inverse relationship between statin use and PCa antitumor action is exemplified by several studies [363,379,380,381,382,383], which target major oncogenic/metabolic pathways such as AR-AKT complex and molecular mediators such as MK167 and cMYC [380]. This evidence concerns the gene AR and posterior cortical atrophy.